Evolent Health (EVH) Misses Q3 EPS by 6c, Beats on Revenue

Evolent Health (NYSE: EVH) reported Q3 EPS of $0.05, $0.06 worse than the analyst estimate of $0.11. Revenue for the quarter came in at $479.53 million versus the consensus estimate of $467.49 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Worthington Industries (WOR) Misses Q4 EPS by 9c
• Goldman Sachs Assumes Klaviyo Inc (KVYO) at Buy